Wu, Jiao
Minikes, Alexander M.
Gao, Minghui
Bian, Huijie
Li, Yong
Stockwell, Brent R.
Chen, Zhi-Nan
Jiang, Xuejun
Article History
Received: 7 November 2018
Accepted: 27 June 2019
First Online: 24 July 2019
Change Date: 2 August 2019
Change Type: Correction
Change Details: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: B.R.S. holds equity in and serves as a consultant to Inzen Therapeutics, consults with GLG and Guidepoint Global, and is an inventor on patents and patent applications related to IKE and ferroptosis.